Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola
Abstract Background Plasmodium falciparum resistance to chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) has historically posed a major threat to malaria control throughout the world. The country of Angola officially replaced CQ with artemisinin-based combination therapy (ACT) as a first-line tre...
Main Authors: | Emily R. Ebel, Fátima Reis, Dmitri A. Petrov, Sandra Beleza |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12936-021-03713-2 |
Similar Items
-
Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018–2019
by: Abdul Qader Khan, et al.
Published: (2020-06-01) -
Artemether-lumefantrine treatment failure of uncomplicated Plasmodium falciparum malaria in travellers coming from Angola and Mozambique
by: André Silva-Pinto, et al.
Published: (2021-09-01) -
Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian–Mauritanian border
by: Mohamed Salem Ould Ahmedou Salem, et al.
Published: (2017-04-01) -
A four-year surveillance program for detection of Plasmodium falciparum chloroquine resistance in Honduras
by: Gustavo A Fontecha, et al.
Published: (2014-07-01) -
Artemether–lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study
by: Mekonnen Gebremichael Gebrekidan, et al.
Published: (2020-11-01)